StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Earnings

Integrated BioPharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 10, 2027
Q2 FY2027 · estimated, during market hours
Revenue, Q1 FY2027
$9.90M
-22.0% on a year earlier
EPS, Q1 FY2027
-$0.02
$0.00 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Integrated BioPharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2027ended Dec 31, 2026Feb 10, 2027Expected––––
Q1 FY2027ended Sep 30, 2026Nov 13, 2026during market hours$9.90M-22.0%-$0.02Release
Q4 FY2026ended Jun 30, 2026Sep 25, 2026during market hours$9.80M-31.0%-$0.04Release
Q3 FY2026ended Mar 31, 2026May 8, 2026during market hours$10.10M-27.3%-$0.03Release
Q2 FY2026ended Dec 31, 2025Feb 11, 2026during market hours$11.30M-10.3%-$0.03Release
Q1 FY2026ended Sep 30, 2025Nov 10, 2025during market hours$12.70M-6.6%$0.00Release
Q4 FY2025ended Jun 30, 2025Sep 23, 2025during market hours$14.20M–-$0.01Release
Q3 FY2025ended Mar 31, 2025May 14, 2025during market hours$13.90M–$0.02Release
Q2 FY2025ended Dec 31, 2024Feb 13, 2025during market hours$12.60M–$0.00Release
Q1 FY2025ended Sep 30, 2024Nov 14, 2024during market hours$13.60M–$0.01Release
Q4 FY2024ended Jun 30, 2024Sep 23, 2024before the open–––Release
Q3 FY2024ended Mar 31, 2024May 10, 2024during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Integrated BioPharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Integrated BioPharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Integrated BioPharma filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?